🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalUK people - is Boots ever actually in stock?? — 12 month update Page 4

UK people - is Boots ever actually in stock?? — 12 month update

BariatricNurseD Sat, Mar 15, 2025 at 8:37 PM 39 replies 2,469 viewsPage 4 of 8
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Mar 17, 2025 at 2:42 AM#16

Adding the clinical framing, because it changes how the question reads. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

Last edited: Mar 17, 2025 at 8:42 AM
26 1Dr.LipidDallas, alex_tucson, kevin_tulsa and 23 others
Reply Quote Save Share Report
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Mar 17, 2025 at 6:02 AM#17
labquiet_amy said:
Keep the original post as written when you update it, and add the correction underneath.

No disagreement, though it depends on where somebody is starting from, and this thread has been assuming a starting point nobody stated.

Last edited: Mar 17, 2025 at 8:02 AM
25 0SleepFixSam, PurityPaulOR, MaxMetOK and 22 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Mar 17, 2025 at 9:22 AM#18
labquiet_amy said:
Keep the original post as written when you update it, and add the correction underneath.

Bookmarking. The distinction being drawn above is the one nobody else makes. I will report back once I have actually tried it.

24 24BrianDallas92, labquiet_amy, emily_PDX and 21 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Mar 17, 2025 at 12:42 PM#19

From the other side of the consultation, briefly. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

Last edited: Mar 17, 2025 at 3:42 PM
23 23LondonLisa, mike_nyc, VendorMark and 20 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 17, 2025 at 4:02 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Carry on.

Last edited: Mar 17, 2025 at 8:02 PM
1 1PeptideSynthNJ
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register